Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors

Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors

Background Urogenital atrophy (UA) is a common treatment-limiting side effect of endocrine therapies. Topical estrogen is effective but systemic absorption may counter aromatase inhibitor efficacy. Numerous complementary approaches are marketed for use in UA without rigorous testing of their estroge...

Full description

Bibliographic Details
Main Authors: Bruno M. Simões, Bertram Kohler, Robert B. Clarke, Jacqui Stringer, Lily Novak-Frazer, Keely Young, Riina Rautemaa-Richardson, Giorgia Zucchini, Anne Armstrong, Sacha J. Howell
Format: Article
Language:English
Published: SAGE Publishing 2018-03-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835918766189

Internet

https://doi.org/10.1177/1758835918766189

Similar Items